Brief: Corline Biomedical Says FDA Approves Kardium's Globe Pulsed Field System
Sept 1 (Reuters) - Corline Biomedical AB CLBIO.ST: FDA APPROVES KARDIUM'S GLOBE® PULSED FIELD SYSTEM Source text: ID:nGNE8zSdlk Further company coverage: CLBIO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln